We are live on ! Find out more
DIM

DC Investments Management Portfolio holdings

AUM $261M
1-Year Est. Return 20.71%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$172M
AUM Growth
-$6.33M
Cap. Flow
-$4.45M
Cap. Flow %
-2.59%
Top 10 Hldgs %
21.38%
Holding
368
New
43
Increased
87
Reduced
135
Closed
64

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$2.04M
2
MPC icon
Marathon Petroleum
MPC
+$2.02M
3
VLO icon
Valero Energy
VLO
+$2M
4
PSX icon
Phillips 66
PSX
+$1.89M
5
INMD icon
InMode
INMD
+$1.01M

Top Sells

Rank Stock Value
1
MIST icon
Milestone Pharmaceuticals
MIST
+$1.06M
2
CBLK
Carbon Black, Inc. Common Stock
CBLK
+$926K
3
GS icon
Goldman Sachs
GS
+$866K
4
ZM icon
Zoom
ZM
+$859K
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$845K

Sector Composition

Rank Sector Weight
1 Healthcare 18.21%
2 Energy 15.61%
3 Financials 14.98%
4 Technology 11.26%
5 Utilities 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PARR icon
1
Par Pacific Holdings
PARR
$4.17B
$11.7M 6.79%
511,378
– –
CC icon
2
Chemours
CC
$2.48B
$5.36M 3.11%
358,782
– –
DK icon
3
Delek US
DK
$3.98B
$5.08M 2.95%
139,880
– –
EVH icon
4
Evolent Health
EVH
$371M
$3.35M 1.94%
465,717
+284,119
+156% +$2.04M
AA icon
5
Alcoa
AA
$11.3B
$2.85M 1.65%
141,959
– –
MPC icon
6
Marathon Petroleum
MPC
$90.1B
$2.33M 1.35%
+38,391
New +$2.02M
VLO icon
7
Valero Energy
VLO
$89.5B
$2.11M 1.22%
+24,747
New +$2M
PSX icon
8
Phillips 66
PSX
$82.9B
$1.93M 1.12%
+18,890
New +$1.89M
MDT icon
9
Medtronic
MDT
$112B
$1.1M 0.64%
10,177
-1,077
-10% -$112K
NVO
10
Novo Nordisk
NVO
$228B
$1.03M 0.6%
39,980
+5,428
+16% +$137K
SNN icon
11
Smith & Nephew
SNN
$13.7B
$1.01M 0.59%
21,008
-1,807
-8% -$83.1K
CCEP icon
12
Coca-Cola Europacific Partners
CCEP
$49.1B
$959K 0.56%
17,290
+524
+3% +$29.3K
INMD icon
13
InMode
INMD
$871M
$951K 0.55%
+88,432
New +$1.01M
NVS icon
14
Novartis
NVS
$302B
$945K 0.55%
10,876
– –
ACN icon
15
Accenture
ACN
$106B
$924K 0.54%
4,805
-367
-7% -$71K
AZN icon
16
AstraZeneca
AZN
$269B
$921K 0.53%
10,327
– –
IBM icon
17
IBM
IBM
$213B
$895K 0.52%
6,438
+4,819
+298% +$650K
STE icon
18
Steris
STE
$22.9B
$860K 0.5%
5,954
-744
-11% -$111K
FSCT
19
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$841K 0.49%
22,190
+3,914
+21% +$143K
SNY icon
20
Sanofi
SNY
$107B
$836K 0.49%
18,048
-5,064
-22% -$218K
VRNS icon
21
Varonis Systems
VRNS
$4.67B
$804K 0.47%
40,341
+6,030
+18% +$134K
RPD icon
22
Rapid7
RPD
$628M
$767K 0.45%
16,887
+2,593
+18% +$146K
PANW icon
23
Palo Alto Networks
PANW
$256B
$763K 0.44%
22,446
+4,200
+23% +$149K
FTNT icon
24
Fortinet
FTNT
$112B
$758K 0.44%
49,400
+8,610
+21% +$140K
GSK icon
25
GSK
GSK
$107B
$752K 0.44%
14,090
-4,108
-23% -$211K
1
2 3 4 5

Similar funds

DC
Dayah Capital Stamford, Connecticut $261M AUM
AFC
Adaptive Financial Consulting Beachwood, Ohio $261M AUM 8.02% 1-Year Est. Return
TIG
Tribune Investment Group New York $261M AUM 70.13% 1-Year Est. Return
GTAM
Global Trust Asset Management West Palm Beach, Florida $262M AUM 50.53% 1-Year Est. Return
MCS
Mercuria Capital Strategies Houston, Texas $262M AUM 90.53% 1-Year Est. Return
NG
NWK Group San Francisco, California $261M AUM 50.13% 1-Year Est. Return
ICM
Intrepid Capital Management Jacksonville Beach, Florida $261M AUM 20.02% 1-Year Est. Return
LCM
Lunt Capital Management Holladay, Utah $260M AUM 10.98% 1-Year Est. Return

DC Investments Management's Q3 2019 Portfolio in Review

As of Q3 2019, DC Investments Management held 368 positions worth $172M, down 3.5% from $179M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

DC Investments Management's Q3 2019 filing shows 43 new, 87 increased, 135 reduced and 64 closed positions. Its largest new stake was Marathon Petroleum: 38,391 shares worth $2.33M. The largest sale was Milestone Pharmaceuticals, an estimated $1.06M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Energy and Financials.

  • DC Investments Management's largest Q3 2019 buy was Marathon Petroleum: 38,391 shares worth $2.33M.
  • DC Investments Management added most to Evolent Health in Q3 2019, an estimated $2.04M increase.
  • DC Investments Management's biggest Q3 2019 reduction was AT&T, cutting an estimated $315K.
  • DC Investments Management fully exited Milestone Pharmaceuticals in Q3 2019, selling an estimated $1.06M.
  • DC Investments Management's ten largest holdings make up 21% of its $172M portfolio in Q3 2019.
  • DC Investments Management opened 43 new positions and closed 64 in Q3 2019.
  • DC Investments Management's portfolio value fell 3.5% quarter-over-quarter to $172M.

Based on DC Investments Management's 13F filing for Q3 2019, filed 5 Nov 2019.